Evidence map›Paper›PMID 30413001›Full record

ArticleInternational journal of molecular sciences2018

A Nationwide Survey on Danon Disease in Japan.

Kazuma Sugie, Hirofumi Komaki, Nobuyuki Eura, Tomo Shiota, Kenji Onoue, Hiroyasu Tsukaguchi, Narihiro Minami, Megumu Ogawa, Takao Kiriyama, Hiroshi Kataoka and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Kazuma SugieDepartment of Neurology, Nara Medical University School of Medicine, Nara 634-8521, Japan. ksugie@naramed-u.ac.jp.
Hirofumi KomakiDepartment of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8502, Japan. komakih@ncnp.go.jp.
Nobuyuki EuraDepartment of Neurology, Nara Medical University School of Medicine, Nara 634-8521, Japan. neura@naramed-u.ac.jp.
Tomo ShiotaDepartment of Neurology, Nara Medical University School of Medicine, Nara 634-8521, Japan. shiotatomo@naramed-u.ac.jp.
Kenji OnoueDepartment of Cardiology, Nara Medical University School of Medicine, Nara 634-8521, Japan. konoue@naramed-u.ac.jp.
Hiroyasu TsukaguchiDepartment of Nephrology, Kansai Medical University, Osaka 573-1010, Japan. tsukaguh@hirakata.kmu.ac.jp.ORCID 0000-0001-9563-5356
Narihiro MinamiDepartment of Neuromuscular Research, National Institute of Neurology, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan. minami@ncnp.go.jp.
Megumu OgawaDepartment of Neuromuscular Research, National Institute of Neurology, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan. ogawa@ncnp.go.jp.
Takao KiriyamaDepartment of Neurology, Nara Medical University School of Medicine, Nara 634-8521, Japan. kirinara@yahoo.co.jp.
Hiroshi KataokaDepartment of Neurology, Nara Medical University School of Medicine, Nara 634-8521, Japan. hk55@naramed-u.ac.jp.
Yoshihiko SaitoDepartment of Cardiology, Nara Medical University School of Medicine, Nara 634-8521, Japan. yssaito@naramed-u.ac.jp.
Ikuya NonakaDepartment of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8502, Japan. nonakai@za.cyberhome.ne.jp.
Ichizo NishinoDepartment of Neuromuscular Research, National Institute of Neurology, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan. nishino@ncnp.go.jp.
Nara Medical University · JPNational Center of Neurology and Psychiatry · JPKansai Medical University · JP

Funding

Ministry of Health, Labour and Welfare H29-030
6 · The paper itself

Abstract

Danon disease, an X-linked dominant cardioskeletal myopathy, is caused by primary deficiency of lysosome-associated membrane protein-2 (LAMP-2). To clarify the clinicopathological features and management, we performed the first nationwide, questionnaire-based survey on Danon disease in Japan. A total of 39 patients (17 males, 22 females) from 20 families were identified in the analysis. All patients had cardiomyopathy. Of the 21 patients who died, 20 (95%) died of cardiac failure or sudden cardiac arrest. Most patients had hypertrophic cardiomyopathy. Wolf⁻Parkinson⁻White syndrome was present at a comparatively high incidence (54% in males, 22% in females). Only one female patient received a heart transplant, which is the most effective therapy. Histopathologically, all male patients showed autophagic vacuoles with sarcolemmal features in muscle. Half of the probands showed de novo mutations. Male patients showed completely absent LAMP-2 expression in muscle. In contrast, female patients showed decreased LAMP-2 expression, which is suggested to reflect LAMP-2 haploinsufficiency due to a heterozygous null mutation. In conclusion, Danon disease is an extremely rare muscular disorder in Japan. Cardiomyopathy is the most significant prognostic factor and the main cause of death. Our findings suggest that the present survey can extend our understanding of the clinical features of this rare disease.

Indexed as

CardiomyopathiesFemaleGene Expression RegulationGlycogen Storage Disease Type IIbHumansJapanLysosomal-Associated Membrane Protein 2MaleMuscle, SkeletalSex CharacteristicsSurveys and QuestionnairesLAMP2 protein, humanLysosomal-Associated Membrane Protein 2autophagic vacuoles with sarcolemmal features (AVSF)autophagycerebral infarctionDanon diseaseheart transplantationhypertrophic cardiomyopathylysosome-associated membrane protein-2 (LAMP-2)myopathyWolf–Parkinson–White (WPW) syndrome

Identifiers

PMID30413001
PMCPMC6274850
OpenAlexW2899875844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.